 |
인쇄하기
취소
|
Yooyoung launches alprostadil cream
Yooyoung Pharm says it has launched Befar (alprostadil) cream in Korea through its exclusive agreement with the U.S. based Nexmed Co.
Befar has shown a clinical efficacy of up to 83% in patients with varying degrees of erectile dysfunction (ED). The cream itself has a onset action of 10-15 minutes and can continue on past 4-hours, and is favorably comparable to the efficacy of the injectable...
Befar has shown a clinical efficacy of up to 83% in patients with varying degrees of erectile dysfunction (ED). The cream itself has a onset action of 10-15 minutes and can continue on past 4-hours, and is favorably comparable to the efficacy of the injectable...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.